Bio Financial Statements From 2010 to 2024
| BIOV Stock | ILS 26.50 1.20 4.74% |
Check Bio View financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Bio View's main balance sheet or income statement drivers, such as , as well as many indicators such as . Bio financial statements analysis is a perfect complement when working with Bio View Valuation or Volatility modules.
Bio |
Bio View Company Operating Margin Analysis
Bio View's Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.
Current Bio View Operating Margin | 0.02 % |
Most of Bio View's fundamental indicators, such as Operating Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Bio View is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
A good Operating Margin is required for a company to be able to pay for its fixed costs or payout its debt, which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against a firm's competitors.
| Competition |
Based on the recorded statements, Bio View has an Operating Margin of 0.0204%. This is 100.06% lower than that of the Health Care Equipment & Supplies sector and 100.05% lower than that of the Health Care industry. The operating margin for all Israel stocks is 100.37% lower than that of the firm.
Bio View Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Bio View's current stock value. Our valuation model uses many indicators to compare Bio View value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Bio View competition to find correlations between indicators driving Bio View's intrinsic value. More Info.Bio View is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers reporting about 0.23 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Bio View is roughly 4.38 . Comparative valuation analysis is a catch-all model that can be used if you cannot value Bio View by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Bio View's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.About Bio View Financial Statements
Bio View stakeholders use historical fundamental indicators, such as Bio View's revenue or net income, to determine how well the company is positioned to perform in the future. Although Bio View investors may analyze each financial statement separately, they are all interrelated. For example, changes in Bio View's assets and liabilities are reflected in the revenues and expenses on Bio View's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Bio View. Please read more on our technical analysis and fundamental analysis pages.
BioView Ltd. develops, manufactures, and markets automated cell imaging and analysis solutions for use in cytology, cytogenetic, and pathology clinical and research laboratories in Israel and internationally. The company was founded in 2000 and is headquartered in Rehovot, Israel. BIO VIEW is traded on Tel Aviv Stock Exchange in Israel.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Bio Stock
Bio View financial ratios help investors to determine whether Bio Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Bio with respect to the benefits of owning Bio View security.